Bone Therapeutics Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
100
- Latest Deal Type
-
M&A
- Investors
-
1
Bone Therapeutics General Information
Description
Developer of cell therapy products intended to address unmet medical needs in the field of orthopaedics and bone diseases. The company's product pipeline includes ALLOB for the treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion and PREOB and is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.
Contact Information
Website
www.bonetherapeutics.comCorporate Office
- Rue Granbonpre 11
- Batiment H bte 24
- 1435 Mont-St-Guibert
- Belgium
Corporate Office
- Rue Granbonpre 11
- Batiment H bte 24
- 1435 Mont-St-Guibert
- Belgium
Bone Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 25-Oct-2022 | Completed | Generating Revenue | |||
| 15. Debt - General | 01-May-2022 | Completed | ||||
| 14. PIPE | 03-Dec-2021 | Completed | Generating Revenue | |||
| 13. PIPE | 16-Dec-2020 | Completed | Generating Revenue | |||
| 12. PIPE | 27-Jun-2019 | Completed | Generating Revenue | |||
| 11. IPO | 06-Feb-2015 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jan-2015 | Completed | Generating Revenue | |||
| 9. IPO | 25-Feb-2013 | Cancelled | Generating Revenue | |||
| 8. Grant | 28-Jan-2013 | $2.12M | $42.3M | Completed | Generating Revenue | |
| 7. Later Stage VC (Series D) | 28-Jan-2013 | $8.09M | $42.3M | Completed | Generating Revenue |
Bone Therapeutics Comparisons
Industry
Financing
Details
Bone Therapeutics Competitors (27)
One of Bone Therapeutics’s 27 competitors is JW Therapeutics, a Formerly VC-backed company based in Shanghai, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| JW Therapeutics | Formerly VC-backed | Shanghai, China | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
| Gamida Cell | Formerly VC-backed | Boston, MA | ||||
| Aura Biosciences | Formerly VC-backed | Cambridge, MA |
Bone Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bone Therapeutics Patents
Bone Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220241205-A1 | Improved lyophilized formulations involving hyaluronic acid and plasmatic proteins, and uses thereof | Inactive | 13-May-2019 | ||
| CA-3137246-A1 | Improved lyophilized formulations involving hyaluronic acid and plasmatic proteins, and uses thereof | Pending | 13-May-2019 | ||
| US-20210404961-A1 | Methods and uses for determining osteogenic potential of in vitro differentiated cells | Inactive | 25-Sep-2018 | ||
| AU-2019349633-A1 | Methods and uses for determining osteogenic potential of in vitro differentiated cells | Inactive | 25-Sep-2018 | ||
| EP-3856932-A1 | Methods and uses for determining osteogenic potential of in vitro differentiated cells | Inactive | 25-Sep-2018 | G01N21/6428 |
Bone Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bone Therapeutics Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 50 North Ventures | Venture Capital | Minority | ||
| BAMS Angels Fund | Angel Group | Minority | ||
| Compagnie du Bois Sauvage | Holding Company | Minority | ||
| Federal Holding and Investment Company | Holding Company | Minority | ||
| Life Sciences Research Partners | Not-For-Profit Venture Capital | Minority |
Bone Therapeutics Investments & Acquisitions (2)
Bone Therapeutics’s most recent deal was a Reverse Merger with BioSenic for . The deal was made on 25-Oct-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BioSenic | 25-Oct-2022 | Reverse Merger | Drug Discovery | ||
| Société d'Infrastructures, de Services et d'Energies | 01-May-2014 | Early Stage VC | Construction and Engineering |
Bone Therapeutics FAQs
-
When was Bone Therapeutics founded?
Bone Therapeutics was founded in 2006.
-
Where is Bone Therapeutics headquartered?
Bone Therapeutics is headquartered in Mont-St-Guibert, Belgium.
-
What is the size of Bone Therapeutics?
Bone Therapeutics has 100 total employees.
-
What industry is Bone Therapeutics in?
Bone Therapeutics’s primary industry is Biotechnology.
-
Is Bone Therapeutics a private or public company?
Bone Therapeutics is a Private company.
-
What is Bone Therapeutics’s current revenue?
The current revenue for Bone Therapeutics is .
-
How much funding has Bone Therapeutics raised over time?
Bone Therapeutics has raised $127M.
-
Who are Bone Therapeutics’s investors?
50 North Ventures, BAMS Angels Fund, Compagnie du Bois Sauvage, Federal Holding and Investment Company, and Life Sciences Research Partners are 5 of 10 investors who have invested in Bone Therapeutics.
-
Who are Bone Therapeutics’s competitors?
JW Therapeutics, CytomX Therapeutics, Dicerna Pharmaceuticals, Gamida Cell, and Aura Biosciences are some of the 27 competitors of Bone Therapeutics.
-
When was Bone Therapeutics acquired?
Bone Therapeutics was acquired on 25-Oct-2022.
-
Who acquired Bone Therapeutics?
Bone Therapeutics was acquired by BioSenic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
